Dupont Capital Management’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-73,075
| Closed | -$687K | – | 1537 |
|
|
2020
Q3 | $687K | Buy |
73,075
+3,500
| +5% | +$33.3K | 0.02% | 628 |
|
|
2020
Q2 | $532K | Sell |
69,575
-15,735
| -18% | -$120K | 0.01% | 748 |
|
|
2020
Q1 | $527K | Buy |
85,310
+11,500
| +16% | +$101K | 0.01% | 644 |
|
|
2019
Q4 | $898K | Sell |
73,810
-4,500
| -6% | -$49.2K | 0.02% | 608 |
|
|
2019
Q3 | $904K | Sell |
78,310
-4,282
| -5% | -$45.1K | 0.02% | 555 |
|
|
2019
Q2 | $825K | Sell |
82,592
-2,385
| -3% | -$25.7K | 0.02% | 599 |
|
|
2019
Q1 | $1.09M | Hold |
84,977
| – | – | 0.03% | 524 |
|
|
2018
Q4 | $1.29M | Buy |
84,977
+19,000
| +29% | +$362K | 0.03% | 465 |
|
|
2018
Q3 | $1.32M | Hold |
65,977
| – | – | 0.03% | 498 |
|
|
2018
Q2 | $1.29M | Buy |
65,977
+1,627
| +3% | +$36K | 0.03% | 485 |
|
|
2018
Q1 | $1.3M | Buy |
64,350
+34,319
| +114% | +$581K | 0.03% | 446 |
|
|
2017
Q4 | $398K | Buy |
30,031
+10,300
| +52% | +$155K | 0.01% | 706 |
|
|
2017
Q3 | $364K | Buy |
19,731
+10,000
| +103% | +$186K | 0.01% | 731 |
|
|
2017
Q2 | $179K | Sell |
9,731
-12,717
| -57% | -$252K | ﹤0.01% | 823 |
|
|
2017
Q1 | $506K | Sell |
22,448
-17,824
| -44% | -$427K | 0.01% | 693 |
|
|
2016
Q4 | $1.4M | Buy |
40,272
+8,371
| +26% | +$250K | 0.03% | 408 |
|
|
2016
Q3 | $782K | Sell |
31,901
-1,937
| -6% | -$48.4K | 0.02% | 509 |
|
|
2016
Q2 | $809K | Sell |
33,838
-28,355
| -46% | -$650K | 0.02% | 499 |
|
|
2016
Q1 | $1.46M | Hold |
62,193
| – | – | 0.03% | 375 |
|
|
2015
Q4 | $1.88M | Buy |
62,193
+20,523
| +49% | +$663K | 0.05% | 356 |
|
|
2015
Q3 | $1.66M | Sell |
41,670
-79,896
| -66% | -$4.96M | 0.04% | 362 |
|
|
2015
Q2 | $8.39M | Buy |
121,566
+8,512
| +8% | +$536K | 0.18% | 117 |
|
|
2015
Q1 | $6.18M | Buy |
113,054
+39,293
| +53% | +$1.87M | 0.12% | 163 |
|
|
2014
Q4 | $3.14M | Buy |
+73,761
| New | +$2.67M | 0.06% | 264 |
|
Dupont Capital Management's AMAG Position: Q4 2020 in Review
Dupont Capital Management sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 73,075 shares — an estimated $687K sold.
Dupont Capital Management first reported a position in AMAG in Q4 2014 and held it in 24 quarters. The position peaked at $8.39M in Q2 2015. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Dupont Capital Management reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Dupont Capital Management sold 73,075 AMAG Pharmaceuticals shares in Q4 2020, an estimated $687K.
- Dupont Capital Management first reported a position in AMAG Pharmaceuticals in Q4 2014 and held it in 24 quarters.
- Dupont Capital Management's AMAG Pharmaceuticals position peaked at $8.39M in Q2 2015.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Dupont Capital Management's 13F filing for Q4 2020, filed 28 Jan 2021.